Automated Density Gradient Cell Separation System

What is the Automated Density Gradient Cell Separation System?

An automated density gradient cell separation system layers blood or bone marrow over a density medium, centrifuges and collects the target interface automatically under closed conditions, reducing operator variation in mononuclear cell preparation.

Overview

The instrument uses a closed, single-use processing set. Blood is layered over a density gradient medium such as a polysaccharide-sodium diatrizoate solution, the chamber is centrifuged so that mononuclear cells collect at the plasma-medium interface while red cells and granulocytes sediment, and the interface layer is then transferred into a collection bag or tube. Automatic optical or volume sensors determine the collection point, which improves consistency compared with manual pipetting. Typical recovery of mononuclear cells from peripheral blood is 60–90% with viability above 95%, and a run takes 20–40 minutes for 10–120 mL of starting material. Because the process is closed, it suits cell therapy starting material preparation where sterility and traceability are essential.

How does it work?

Separation exploits a physical or biochemical difference between the target and the rest of the sample. Immunomagnetic methods coat cells with antibody-conjugated magnetic particles and either retain labelled cells in a column placed in a magnetic field, or label everything except the target and let the desired cells flow through untouched. Fluorescence-activated sorting stains cells with fluorescent antibodies, interrogates each cell in a fluid stream and applies a charge to the droplet containing a selected cell, which is then deflected into a collection tube. Microfluidic sorters use narrow channels, acoustic waves or optical forces to deflect cells without droplets. Density-based separation layers the sample over a medium of defined density so that cells of different density band at different interfaces during centrifugation. Each method trades purity, yield, speed and gentleness differently, and downstream assays determine which balance is acceptable.

What are the key features?

• Closed single-use processing set for sterility
• Automatic layering, centrifugation and interface collection
• Optical or volume sensor determines the collection point
• Mononuclear cell recovery of 60–90% with viability above 95%
• Run time of 20–40 minutes for up to 120 mL of sample
• Process records for traceability in regulated workflows

What are the technical specifications?

A typical automated density gradient cell separation system configuration offers sample volume of 10–120 mL, run time of approx. 20–40 min, mononuclear cell recovery of 60–90%, viability of above 95% (typical), density medium of Polysaccharide and diatrizoate solution, 1.077 g/mL and centrifugation of approx. 400–800 x g for 20–30 min. Values are indicative of the product class; the exact figures for each configuration are confirmed on the quotation and the calibration documents supplied with the instrument.

Which applications is it used for?

The Automated Density Gradient Cell Separation System is used in peripheral blood mononuclear cell preparation, cell therapy starting material processing, bone marrow mononuclear cell isolation and blood bank and research sample fractionation. Across the wider Cell Separation class, laboratories also deploy it for T cell and immune subset isolation, stem cell and progenitor enrichment and cell therapy starting material preparation.

Which standards and certifications apply?

Relevant standards and methods include ISO 20387, USP <1046>, IEC 61010-1, IEC 61010-2-020, IEC 60825-1 and ISO 15189. Certification candidates for this model are CE, ISO 13485 manufacturing, ISO 9001 manufacturing and IEC 61010-2-020 safety; each is to be confirmed for the specific configuration before shipment, and certificates are supplied only where they have been issued.

Work in a biosafety cabinet with appropriate containment, and keep separation buffers cold unless the protocol states otherwise, since cells are more sensitive to handling than to the method itself. Use fresh antibodies and beads, avoid vigorous pipetting, and filter samples through a 30–40 µm mesh to prevent column or nozzle blockage. Include a dead-cell removal step, because dead cells bind non-specifically and reduce purity. After separation, verify purity and viability by flow cytometry and record recovery and purity values for each preparation. Aseptic technique and closed systems are required for cell therapy workflows, where separation is part of a validated process under ISO 20387 and USP <1046> expectations, including documented operator training and traceability of reagents and lots.

How do I select the right Automated Density Gradient Cell Separation System?

Select an automated density gradient system when mononuclear cells must be prepared reproducibly in a closed, traceable process, especially for cell therapy. Specify sample volume range, recovery and viability expectations, process set availability and the level of process documentation provided.

How does it compare with other Cell Separation variants?

Choose by the required purity, yield, cell number and downstream application. Magnetic separation is fast, gentle and scalable, works with 10⁷ to 10⁹ cells and needs no sorter, but purity is typically 90–98%, so it may not be sufficient for single-cell sequencing. Fluorescence-activated sorting reaches 98–99.9% purity, can deposit single cells into plates with index information and supports multi-parameter gating, at the cost of lower throughput, higher shear stress and specialised operation. Microfluidic and acoustic methods suit low-volume samples and cell types sensitive to shear. Density gradient separation remains the standard first step for blood and bone marrow, followed by magnetic or flow-based purification. Confirm compatibility of labels, buffers and consumables with downstream culture, functional assays and regulatory requirements.